Swisslog Healthcare Partners with BD to Automate Pharmacy Inventory in US Hospitals

Swisslog Healthcare, a leader in robotic medication management solutions, has partnered with BD, a global medical technology company, to co-market an innovative solution for hospital pharmacies. This collaboration integrates Swisslog’s advanced robotics with BD’s top-tier inventory management and workflow software,…

Read MoreSwisslog Healthcare Partners with BD to Automate Pharmacy Inventory in US Hospitals

Lantern Pharma Enrolls First Patient in Taiwan for Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker NSCLC

Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven company developing targeted cancer therapies through its proprietary RADR® AI platform, announced today the enrollment and dosing of the first patient in Taiwan for its Phase 2 HARMONIC™ clinical trial. The trial is…

Read MoreLantern Pharma Enrolls First Patient in Taiwan for Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker NSCLC

Health Canada Approves Celltrion’s Omlyclo™ (CT-P39), Canada’s First Omalizumab Biosimilar

Celltrion announced today that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is now approved for the treatment of adults and adolescents with chronic idiopathic urticaria (CIU), also known as chronic spontaneous urticaria (CSU), as well as for…

Read MoreHealth Canada Approves Celltrion’s Omlyclo™ (CT-P39), Canada’s First Omalizumab Biosimilar

Intelliguard and Codonics Partner to Enhance Patient Safety

Intelliguard, a leading provider of RFID-enabled medication management and data-intelligence solutions, has announced a strategic partnership with Codonics, a global leader in healthcare technology focused on patient safety. This collaboration integrates Intelliguard’s Mira Care Station with Codonics’ Safe Label System…

Read MoreIntelliguard and Codonics Partner to Enhance Patient Safety

DNAnexus and Panomics Partner to Provide Multi-omics Data Solutions for Biopharma

DNAnexus, Inc., a leader in precision health data platforms, and Panomics, Inc., specializing in AI-powered omics data management and discovery for biopharma, have announced a strategic collaboration. This partnership will deliver biopharma organizations a comprehensive solution for multi-omics data management…

Read MoreDNAnexus and Panomics Partner to Provide Multi-omics Data Solutions for Biopharma

Five-Year Results Confirm Genentech’s Polivy Combo as New Standard for Untreated Aggressive Lymphoma

Genentech, a member of the Roche Group, today announced five-year follow-up data from the pivotal Phase III POLARIX study. The study evaluated Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab), cyclophosphamide, doxorubicin, and prednisone (R-CHP) in patients with untreated diffuse…

Read MoreFive-Year Results Confirm Genentech’s Polivy Combo as New Standard for Untreated Aggressive Lymphoma